Literature DB >> 3337158

Umbilical amino acid concentrations in appropriate and small for gestational age infants: a biochemical difference present in utero.

I Cetin1, A M Marconi, P Bozzetti, L P Sereni, C Corbetta, G Pardi, F C Battaglia.   

Abstract

Plasma amino acid concentrations were determined in 28 pregnant women and their infants at term. Samples were obtained from 17 appropriate for gestational age and eight small for gestational age infants at cesarean section, while three small for gestational age fetuses were studied in utero by transabdominal cord sampling by means of ultrasonic guidance. Small for gestational age fetuses have significantly lower concentrations of alpha-aminonitrogen, compared with those of appropriate for gestational age fetuses, in both the umbilical artery and vein. Most of the difference is accounted for by the branched chain amino acids valine, leucine, and isoleucine. In contrast, hydroxyproline concentration is significantly higher in both the umbilical artery and vein of small for gestational age fetuses. The sum of the branched chain amino acid concentrations in the umbilical vein is directly related to maternal arterial values in both appropriate for gestational age and small for gestational age fetuses. Maternal arterial concentrations were slightly lower in small for gestational age fetuses and the regression analysis of umbilical venous versus maternal arterial branched chain amino acid concentrations was significantly different for small for gestational age and appropriate for gestational age infants. Umbilical venoarterial concentration differences in normal fetuses are significantly positive for most essential amino acids and for total alpha-aminonitrogen. In contrast, these differences were significant only for four essential amino acids in small for gestational age infants, while the total alpha-aminonitrogen venoarterial difference was not significant. The data obtained by transabdominal cord sampling from relatively undisturbed fetuses were in agreement with the data obtained at cesarean section; this information suggests that these differences between small for gestational age and appropriate for gestational age infants reflected steady-state conditions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3337158     DOI: 10.1016/0002-9378(88)90792-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  29 in total

Review 1.  Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis.

Authors:  C N Hales; D J Barker
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

2.  Hyperphosphorylation of fetal liver IGFBP-1 precedes slowing of fetal growth in nutrient-restricted baboons and may be a mechanism underlying IUGR.

Authors:  Jenica H Kakadia; Bhawani B Jain; Kyle Biggar; Austen Sutherland; Karen Nygard; Cun Li; Peter W Nathanielsz; Thomas Jansson; Madhulika B Gupta
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-08-03       Impact factor: 4.310

3.  Facilitated transporters mediate net efflux of amino acids to the fetus across the basal membrane of the placental syncytiotrophoblast.

Authors:  J K Cleal; J D Glazier; G Ntani; S R Crozier; P E Day; N C Harvey; S M Robinson; C Cooper; K M Godfrey; M A Hanson; R M Lewis
Journal:  J Physiol       Date:  2011-01-04       Impact factor: 5.182

4.  Where the O2 goes to: preservation of human fetal oxygen delivery and consumption at high altitude.

Authors:  Lucrecia Postigo; Gladys Heredia; Nicholas P Illsley; Tatiana Torricos; Caitlin Dolan; Lourdes Echalar; Wilma Tellez; Ivan Maldonado; Michael Brimacombe; Elfride Balanza; Enrique Vargas; Stacy Zamudio
Journal:  J Physiol       Date:  2008-12-15       Impact factor: 5.182

5.  Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction.

Authors:  Majida Abu Shehab; Ian Damerill; Tong Shen; Fredrick J Rosario; Mark Nijland; Peter W Nathanielsz; Amrita Kamat; Thomas Jansson; Madhulika B Gupta
Journal:  Endocrinology       Date:  2014-01-17       Impact factor: 4.736

Review 6.  L-serine in disease and development.

Authors:  Tom J de Koning; Keith Snell; Marinus Duran; Ruud Berger; Bwee-Tien Poll-The; Robert Surtees
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

7.  Increased IGFBP-1 phosphorylation in response to leucine deprivation is mediated by CK2 and PKC.

Authors:  Niyati Malkani; Kyle Biggar; Majida Abu Shehab; Shawn Shun-Cheng Li; Thomas Jansson; Madhulika B Gupta
Journal:  Mol Cell Endocrinol       Date:  2015-12-28       Impact factor: 4.102

8.  Effect of 30% nutrient restriction in the first half of gestation on maternal and fetal baboon serum amino acid concentrations.

Authors:  Thomas J McDonald; Guoyao Wu; Mark J Nijland; Susan L Jenkins; Peter W Nathanielsz; Thomas Jansson
Journal:  Br J Nutr       Date:  2012-10-09       Impact factor: 3.718

9.  Placental transport in response to altered maternal nutrition.

Authors:  F Gaccioli; S Lager; T L Powell; T Jansson
Journal:  J Dev Orig Health Dis       Date:  2013-04       Impact factor: 2.401

10.  Isolation of plasma membrane vesicles from mouse placenta at term and measurement of system A and system beta amino acid transporter activity.

Authors:  L C Kusinski; C J P Jones; P N Baker; C P Sibley; J D Glazier
Journal:  Placenta       Date:  2009-12-01       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.